Conformational Changes and Membrane Interaction of the Bacterial Phospholipase, ExoU: Characterization by Site-Directed Spin Labeling.
EPR
ExoU
Phospholipase
Pseudomonas aeruginosa
Spin labeling
Journal
Cell biochemistry and biophysics
ISSN: 1559-0283
Titre abrégé: Cell Biochem Biophys
Pays: United States
ID NLM: 9701934
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
23
03
2018
accepted:
12
07
2018
pubmed:
27
7
2018
medline:
6
4
2019
entrez:
27
7
2018
Statut:
ppublish
Résumé
Numerous pathogenic bacteria produce proteins evolved to facilitate their survival and dissemination by modifying the host environment. These proteins, termed effectors, often play a significant role in determining the virulence of the infection. Consequently, bacterial effectors constitute an important class of targets for the development of novel antibiotics. ExoU is a potent phospholipase effector produced by the opportunistic pathogen Pseudomonas aeruginosa. Previous studies have established that the phospholipase activity of ExoU requires non-covalent interaction with ubiquitin, however the molecular details of the mechanism of activation and the manner in which ExoU associates with a target lipid bilayer are not understood. In this review we describe our recent studies using site-directed spin labeling (SDSL) and EPR spectroscopy to elucidate the conformational changes and membrane interactions that accompany activation of ExoU. We find that ubiquitin binding and membrane interaction act synergistically to produce structural transitions that occur upon ExoU activation, and that the C-terminal four-helix bundle of ExoU functions as a phospholipid-binding domain, facilitating the association of ExoU with the membrane surface.
Identifiants
pubmed: 30047043
doi: 10.1007/s12013-018-0851-8
pii: 10.1007/s12013-018-0851-8
pmc: PMC6347562
mid: NIHMS1501252
doi:
Substances chimiques
Bacterial Proteins
0
Liposomes
0
Spin Labels
0
Ubiquitin
0
Phospholipases
EC 3.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-87Subventions
Organisme : NIH HHS
ID : S10 OD011937
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI104922
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR022422
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : 104992
Organisme : NIBIB NIH HHS
ID : P41 EB001980
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM114234
Pays : United States
Organisme : National Institute of General Medical Sciences
ID : 114234
Références
Biochemistry. 1999 Mar 9;38(10):2947-55
pubmed: 10074347
Science. 1999 May 21;284(5418):1322-8
pubmed: 10334981
J Magn Reson. 2000 Feb;142(2):331-40
pubmed: 10648151
Biochemistry. 2001 Apr 3;40(13):3828-46
pubmed: 11300763
J Infect Dis. 2001 Jun 15;183(12):1767-74
pubmed: 11372029
Crit Care Med. 2002 Mar;30(3):521-8
pubmed: 11990909
Biochemistry. 2002 May 21;41(20):6282-92
pubmed: 12009889
Biochemistry. 2003 Jan 14;42(1):96-105
pubmed: 12515543
EMBO J. 2003 Jun 16;22(12):2959-69
pubmed: 12805211
J Biol Chem. 2003 Oct 17;278(42):41326-32
pubmed: 12915403
Biophys J. 2004 Jan;86(1 Pt 1):329-36
pubmed: 14695274
Biochemistry. 2004 Jun 15;43(23):7273-87
pubmed: 15182173
Clin Infect Dis. 2004 Aug 1;39(3):309-17
pubmed: 15306996
Science. 2004 Oct 15;306(5695):491-5
pubmed: 15486302
Infect Immun. 2005 Jan;73(1):573-82
pubmed: 15618197
J Bacteriol. 2005 Feb;187(3):1192-5
pubmed: 15659695
Annu Rev Biophys Biomol Struct. 2005;34:119-51
pubmed: 15869386
Biophys J. 2005 Sep;89(3):2103-12
pubmed: 15994891
Biophys J. 2005 Sep;89(3):2059-68
pubmed: 15994892
Infect Immun. 2006 May;74(5):2552-61
pubmed: 16622190
Cell Microbiol. 2006 Aug;8(8):1294-309
pubmed: 16882033
Curr Opin Struct Biol. 2006 Oct;16(5):644-53
pubmed: 16949813
Biophys J. 2007 Sep 1;93(5):1651-60
pubmed: 17496013
Methods Cell Biol. 2008;84:617-58
pubmed: 17964945
Nat Rev Mol Cell Biol. 2008 Feb;9(2):99-111
pubmed: 18216767
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7439-44
pubmed: 18490656
Biochemistry. 2008 Aug 12;47(32):8301-16
pubmed: 18610985
J Bacteriol. 2010 Apr;192(7):1801-12
pubmed: 20097856
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5581-6
pubmed: 20212166
Biophys J. 2010 Mar 17;98(6):L18-20
pubmed: 20303847
Infect Immun. 2010 Aug;78(8):3346-57
pubmed: 20479080
J Magn Reson. 2010 Nov;207(1):164-7
pubmed: 20805036
Biophys J. 2011 Mar 2;100(5):1335-43
pubmed: 21354407
Chem Rev. 2011 Oct 12;111(10):6130-85
pubmed: 21910409
Mol Microbiol. 2011 Dec;82(6):1454-67
pubmed: 22040088
Cell Microbiol. 2012 Feb;14(2):286-98
pubmed: 22044757
Structure. 2011 Nov 9;19(11):1549-61
pubmed: 22078555
Annu Rev Phys Chem. 2012;63:419-46
pubmed: 22404592
PLoS Pathog. 2012;8(4):e1002637
pubmed: 22496657
PLoS One. 2012;7(11):e49388
pubmed: 23166655
Infect Immun. 2013 Aug;81(8):2873-81
pubmed: 23716613
Curr Opin Struct Biol. 2013 Oct;23(5):725-33
pubmed: 23850140
Biochemistry. 2013 Sep 3;52(35):5967-84
pubmed: 23961941
Crit Care Med. 2014 Jan;42(1):48-56
pubmed: 23963124
Annu Rev Microbiol. 2014;68:415-38
pubmed: 25002086
PLoS One. 2014 Jul 25;9(7):e103127
pubmed: 25061861
Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):60-6
pubmed: 25306967
Biophys J. 1989 Dec;56(6):1183-91
pubmed: 2558734
Methods Enzymol. 2015;564:59-100
pubmed: 26477248
Methods Enzymol. 2015;564:349-87
pubmed: 26477257
Angew Chem Int Ed Engl. 2016 Dec 19;55(51):15905-15909
pubmed: 27860003
J Biol Chem. 2017 Feb 24;292(8):3411-3419
pubmed: 28069812
Front Cell Infect Microbiol. 2017 Feb 15;7:39
pubmed: 28261568
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3268-E3275
pubmed: 28373559
Sci Rep. 2017 Dec 8;7(1):17229
pubmed: 29222414
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):525-530
pubmed: 29295930
Anal Biochem. 1982 Jan 15;119(2):450-5
pubmed: 6280514
Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1667-71
pubmed: 8127863
Mol Microbiol. 1997 Aug;25(3):547-57
pubmed: 9302017
Biochemistry. 1997 Oct 21;36(42):13027-33
pubmed: 9335564